Page last updated: 2024-08-17

quinidine and caffeine

quinidine has been researched along with caffeine in 68 studies

Research

Studies (68)

TimeframeStudies, this research(%)All Research%
pre-199024 (35.29)18.7374
1990's5 (7.35)18.2507
2000's20 (29.41)29.6817
2010's19 (27.94)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET1
Topliss, JG; Yoshida, F1
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA1
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY2
Faassen, F; Spanings, H; Vogel, G; Vromans, H1
Jolivette, LJ; Ward, KW1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Alimuddin, M; Bulloch, D; Dahl, R; Grant, D; Lee, N; Peacock, M1
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Campillo, NE; Guerra, A; Páez, JA1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Glen, RC; Lowe, R; Mitchell, JB1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Ekins, S; Williams, AJ; Xu, JJ1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Doh-Ura, K; Go, ML; Nguyen, T; Sakasegawa, Y1
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Handzlik, J; Jastrzębska-Więsek, M; Kieć-Kononowicz, K; Kucwaj-Brysz, K; Latacz, G; Lubelska, A; Partyka, A; Wesołowska, A1
Bojarski, AJ; Cieślik, P; Handzlik, J; Hogendorf, A; Hogendorf, AS; Kieć-Kononowicz, K; Latacz, G; Lubelska, A; Wierońska, JM; Woźniak, M1
Bartel, K; Bracher, F; Christianson, DW; Herp, D; Jung, M; Marek, M; Müller, M; Ong, N; Porter, NJ; Robaa, D; Romier, C; Schmidtkunz, K; Senger, J; Shaik, TB; Sippl, W; Vögerl, K1
Atwater, I; Beigelman, PM1
Huddart, H; Lynch, M1
Lennard, MS; Loft, S; Otton, SV; Poulsen, HE; Tucker, GT1
Rafuse, PE; Smith, PA; Zidichouski, JA1
Guo, JY; He, MS; Zhan, LF; Zhang, YZ1
Foulks, JG; Perry, FA; Sanders, HD1
Foulks, JG; Miller, JA; Perry, FA2
Andersson, KE1
Batra, S1
Thorpe, WR1
Mason, RG; Read, MS; Saba, SR; Shermer, RW1
Praël, E; Strubelt, O1
Bondani, A; Karler, R1
Fairhurst, AS; Hasselbach, W1
Ingenito, A; Katz, NL; Procita, L1
Hartung, K; Hermann, A1
Coleman, RA1
Kulkarni, SK; Mehta, AK1
Libao, RG; Su, JY1
Busselen, P1
Hasegawa, J; Hirai, S; Kotake, H; Mashiba, H; Narasaki, K; Nawada, T; Tsuboi, M1
Begnini, J; Bellot, RG; De-La-Vega, DD; Frussa-Filho, R; Jimenez-Bernal, RE; Lopes, FP; Mello, CF; Schwartz, CC1
Huddart, H; King, JA; Staff, WG1
Adedoyin, A; Branch, RA; Frye, RF; Romkes, M; Wilson, JW1
RUMMEL, W; SCHULZ, R1
MALONE, MH; RAGOZZINO, PW1
DIMASCOLO, R; MASINI, V1
CARLASSARE, M1
Fuhr, U; Kober, S; Mutschler, E; Spahn-Langguth, H; Zaigler, M1
Banić, B; Jakovljević, V; Vasović, V1
Capasso, A; Gallo, C1
Guerin, PM; Kessler, S; Vlimant, M1
Browne, T; Conti, T; Fiorentin, TR; Krotulski, AJ; Logan, BK; Martin, DM; Triplett, J1

Reviews

3 review(s) available for quinidine and caffeine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Ca2+ activated K+ conductance in molluscan neurones.
    Cell calcium, 1983, Volume: 4, Issue:5-6

    Topics: Action Potentials; Animals; Apamin; Aplysia; Binding Sites; Caffeine; Calcium; Electric Conductivity; Gallamine Triethiodide; Helix, Snails; Ion Channels; Membrane Potentials; Mollusca; Neurons; Photoreceptor Cells; Potassium; Quinidine; Quinine; Ruthenium Red; Tetraethylammonium Compounds

1983
[THERAPY OF THE MORGAGNI-ADAMS-STOKES SYNDROME].
    Recenti progressi in medicina, 1964, Volume: 36

    Topics: Adams-Stokes Syndrome; Adrenal Cortex Hormones; Amphetamine; Amphetamines; Amyl Nitrite; Atropine; Barium; Caffeine; Chlorothiazide; Digitalis Glycosides; Electrocardiography; Ephedrine; Epinephrine; Geriatrics; Heart Block; Heart Massage; Humans; Isoproterenol; Lactates; Magnesium Sulfate; Methamphetamine; Procainamide; Purines; Quinidine; Thyroxine

1964

Other Studies

65 other study(ies) available for quinidine and caffeine

ArticleYear
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium

1985
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
    Journal of medicinal chemistry, 2001, Jul-19, Volume: 44, Issue:15

    Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water

2001
Cheminformatic models to predict binding affinities to human serum albumin.
    Journal of medicinal chemistry, 2001, Dec-06, Volume: 44, Issue:25

    Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids

2001
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
    Journal of medicinal chemistry, 2002, Jun-20, Volume: 45, Issue:13

    Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding

2002
Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs.
    International journal of pharmaceutics, 2003, Sep-16, Volume: 263, Issue:1-2

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Caco-2 Cells; Cell Membrane Permeability; Heterocyclic Compounds; Humans; Protein Transport

2003
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
    Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7

    Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution

2005
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Determination of log D via automated microfluidic liquid-liquid extraction.
    Journal of medicinal chemistry, 2008, Aug-28, Volume: 51, Issue:16

    Topics: Automation; Biopharmaceutics; Microfluidic Analytical Techniques; Pharmacokinetics

2008
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:4

    Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software

2009
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
    Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19

    Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Anti-prion activities and drug-like potential of functionalized quinacrine analogs with basic phenyl residues at the 9-amino position.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:7

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport; Blood-Brain Barrier; Cell Line, Tumor; Dogs; Humans; Madin Darby Canine Kidney Cells; Mice; Peptide Fragments; Permeability; Piperazines; Piperidines; Prion Diseases; Prions; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; Quinacrine; Recombinant Proteins; Structure-Activity Relationship

2011
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1

    Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests

2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
MF-8, a novel promising arylpiperazine-hydantoin based 5-HT
    Bioorganic & medicinal chemistry letters, 2018, 03-01, Volume: 28, Issue:5

    Topics: Dose-Response Relationship, Drug; Humans; Hydantoins; Molecular Structure; Piperazines; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship

2018
Search for a 5-CT alternative.
    MedChemComm, 2018, Nov-01, Volume: 9, Issue:11

    Topics:

2018
Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.
    Journal of medicinal chemistry, 2019, 02-14, Volume: 62, Issue:3

    Topics: Acetylation; Animals; Catalytic Domain; Cells, Cultured; Crystallography, X-Ray; Histone Deacetylase 6; Histone Deacetylase Inhibitors; HL-60 Cells; Humans; Hydroxamic Acids; In Vitro Techniques; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Phenothiazines; Structure-Activity Relationship; Zebrafish

2019
Dynamic characteristics of electrical activity in pancreatic beta-cells. I. - Effects of calcium and magnesium removal.
    Journal de physiologie, 1976, Volume: 72, Issue:6

    Topics: Animals; Caffeine; Calcium; Cell Membrane Permeability; Electrophysiology; Exocytosis; Glucose; Islets of Langerhans; Magnesium; Membrane Potentials; Mice; Quinidine

1976
Purinergic modulation of field stimulation responses of rat and human vas deferens smooth muscle.
    General pharmacology, 1991, Volume: 22, Issue:5

    Topics: Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Animals; Caffeine; Electric Stimulation; Guanethidine; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Quinidine; Rats; Receptors, Purinergic; Theophylline; Urinary Bladder; Vas Deferens; Vasodilator Agents

1991
Characterization of metronidazole metabolism by human liver microsomes.
    Biochemical pharmacology, 1991, Apr-15, Volume: 41, Issue:8

    Topics: Acetone; Adult; Benzoflavones; Caffeine; Cytochrome P-450 Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Kinetics; Male; Mephenytoin; Metronidazole; Microsomes, Liver; Middle Aged; Nifedipine; Phenacetin; Quinidine; Theophylline; Tolbutamide

1991
Examination of the role of calcium in the adrenaline-induced hyperpolarization of bullfrog sympathetic neurons.
    Neuroscience, 1988, Volume: 25, Issue:2

    Topics: 4-Aminopyridine; Aminopyridines; Animals; Apamin; Bufonidae; Caffeine; Calcium; Dantrolene; Electrophysiology; Epinephrine; Gallic Acid; Neurons; Potassium; Quinidine; Sympathetic Nervous System; Tetraethylammonium Compounds; Tubocurarine

1988
[Estimation of residual rate and apparent half-life time of drugs using the method of acute mortality of animals].
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1985, Volume: 6, Issue:3

    Topics: Animals; Caffeine; Half-Life; Kinetics; Lethal Dose 50; Mice; Pest Control, Biological; Quinidine; Spores; Sulfadiazine

1985
Augmentation of caffeine-contracture tension by twitch-potentiating agents in frog toe muscle.
    Canadian journal of physiology and pharmacology, 1971, Volume: 49, Issue:10

    Topics: Androstanes; Animals; Anura; Caffeine; Calcium; Cell Membrane; Chloroform; Drug Interactions; Drug Synergism; Ethers; In Vitro Techniques; Magnesium; Membrane Potentials; Muscle Contraction; Neuromuscular Depolarizing Agents; Nitrates; Pentobarbital; Perchlorates; Potassium; Quinidine; Tetraethylammonium Compounds; Toes; Zinc

1971
Repolarization-induced reactivation of contracture tension in frog skeletal muscle.
    Canadian journal of physiology and pharmacology, 1973, Volume: 51, Issue:5

    Topics: Acetates; Animals; Anura; Caffeine; Calcium; Chlorides; Chloroform; Choline; Ethyl Ethers; Ferrocyanides; In Vitro Techniques; Kinetics; Membrane Potentials; Microelectrodes; Muscle Contraction; Muscles; Perchlorates; Potassium; Quinidine; Time Factors

1973
Effects of chlorpromazine, imipramine, and quinidine on the mechanical activity of single skeletal muscle fibres of the frog.
    Acta physiologica Scandinavica, 1972, Volume: 85, Issue:4

    Topics: Animals; Anura; Caffeine; Chlorpromazine; Drug Synergism; Electric Stimulation; Imipramine; Methods; Muscle Contraction; Myofibrils; Potassium; Quinidine; Rana temporaria; Tendons

1972
The effects of drugs on calcium uptake and calcium release by mitochondria and sarcoplasmic reticulum of frog skeletal muscle.
    Biochemical pharmacology, 1974, Jan-01, Volume: 23, Issue:1

    Topics: Animals; Anura; Biological Transport; Brain; Caffeine; Calcium; Chlorpromazine; Imidazoles; In Vitro Techniques; Mitochondria; Mitochondria, Liver; Mitochondria, Muscle; Muscles; Myocardium; Quinidine; Rana temporaria; Sarcoplasmic Reticulum; Time Factors

1974
Some effects of caffeine and quinidine on sarcoplasmic reticulum of skeletal and cardiac muscle.
    Canadian journal of physiology and pharmacology, 1973, Volume: 51, Issue:7

    Topics: Anesthetics, Local; Animals; Caffeine; Calcium; Heart; In Vitro Techniques; Male; Muscles; Myocardium; Quinidine; Rabbits; Sarcoplasmic Reticulum

1973
Restoration of the ability of frog skeletal muscle to develop potassium contractures in calcium-deficient media.
    Canadian journal of physiology and pharmacology, 1973, Volume: 51, Issue:5

    Topics: Acetates; Androstanes; Animals; Anura; Caffeine; Calcium; Chelating Agents; Chlorides; Ethyl Ethers; Ferrocyanides; Glycols; In Vitro Techniques; Kinetics; Magnesium; Muscle Contraction; Muscles; Nitrates; Pentobarbital; Potassium; Quinidine; Tetraethylammonium Compounds; Time Factors; Zinc

1973
Apparent similarity of mechanisms of platelet adhesion and aggregation. Differentiation of these functions from clot retraction.
    Thrombosis et diathesis haemorrhagica, 1972, Feb-29, Volume: 27, Issue:1

    Topics: Amitriptyline; Aspirin; Blood Coagulation Tests; Caffeine; Chloromercuribenzoates; Chlorpromazine; Clot Retraction; Cocaine; Diphenhydramine; Ethacrynic Acid; Guanidines; Humans; Phenothiazines; Phentolamine; Phenylbutazone; Platelet Adhesiveness; Promethazine; Quinacrine; Quinidine; Reserpine; Sulfinpyrazone; Sulfones; Tosyl Compounds

1972
[Pharmacological effects on the contraction frequency of isolated rat portal vein].
    Archives internationales de pharmacodynamie et de therapie, 1972, Volume: 198, Issue:2

    Topics: Aconitum; Animals; Atropine; Caffeine; Carbachol; Epinephrine; Histamine; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Nitrites; Norepinephrine; Papaverine; Peptides; Phentolamine; Portal Vein; Propranolol; Quinidine; Rats; Rats, Inbred Strains; Reserpine; Strophanthins; Theophylline; Tyramine

1972
Interaction of calcium and local anesthetics with skeletal muscle microsomes.
    Journal of cellular physiology, 1970, Volume: 75, Issue:2

    Topics: Anesthetics, Local; Animals; Benzocaine; Binding Sites; Caffeine; Calcium; Calcium Isotopes; Cell Membrane; Cell-Free System; Cytoplasmic Granules; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Muscle Contraction; Muscles; Ouabain; Procaine; Quinidine; Rats; Sodium; Tetracaine

1970
Calcium efflux from a heavy sarcotubular fraction. Effects of ryanodine, caffeine and magnesium.
    European journal of biochemistry, 1970, Volume: 13, Issue:3

    Topics: Alkaloids; Animals; Biological Transport; Caffeine; Calcium; Chlorpromazine; Magnesium; Metabolism; Muscles; Oxalates; Quinidine; Rabbits; Uranium; Zinc

1970
Ryanodine-induced contractile failure of skeletal muscle.
    The Journal of pharmacology and experimental therapeutics, 1970, Volume: 171, Issue:2

    Topics: Animals; Caffeine; Cats; Drug Synergism; Electric Stimulation; Epinephrine; Female; Male; Muscle Contraction; Muscles; Quinidine

1970
Purine antagonists in the identification of adenosine-receptors in guinea-pig trachea and the role of purines in non-adrenergic inhibitory neurotransmission.
    British journal of pharmacology, 1980, Volume: 69, Issue:3

    Topics: Adenosine; Animals; Caffeine; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Male; Phenoxybenzamine; Phentolamine; Purines; Quinidine; Receptors, Drug; Synaptic Transmission; Trachea; Xanthines

1980
Evidence for the presence of P1- and P2-purinoceptors in rat caecum.
    Archives internationales de pharmacodynamie et de therapie, 1983, Volume: 264, Issue:2

    Topics: 2-Chloroadenosine; Adenosine; Adenosine Triphosphate; Animals; Caffeine; Cecum; Cyclic AMP; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Quinidine; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic; Theophylline

1983
Intracellular mechanism of quinidine action on muscle contraction. A comparison between rabbit cardiac and skeletal muscle.
    Naunyn-Schmiedeberg's archives of pharmacology, 1984, Volume: 326, Issue:4

    Topics: Animals; Caffeine; Calcium; In Vitro Techniques; Magnesium; Muscle Contraction; Muscle Proteins; Muscles; Myocardial Contraction; Quinidine; Rabbits

1984
Effects of caffeine and other substances on sodium- and calcium-independent efflux in cyanide poisoned goldfish ventricles.
    Archives internationales de pharmacodynamie et de therapie, 1980, Volume: 244, Issue:2

    Topics: Animals; Biological Transport, Active; Caffeine; Calcium; Cyanides; Goldfish; In Vitro Techniques; Myocardium; Naphazoline; Quinidine; Sarcoplasmic Reticulum; Theophylline

1980
Quinidine enhances intracellular Ca2+ accumulation during rapid stimulation.
    General pharmacology, 1995, Volume: 26, Issue:5

    Topics: Animals; Caffeine; Calcium; Electric Stimulation; Fura-2; Guinea Pigs; Heart; In Vitro Techniques; Myocardium; Quinidine; Systole

1995
Antinociceptive effect of purine nucleotides.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1996, Volume: 29, Issue:10

    Topics: Analgesics; Animals; Caffeine; Male; Mice; Naloxone; Narcotic Antagonists; Nociceptors; Purine Nucleotides; Quinidine; Receptors, Purinergic P1; Receptors, Purinergic P2; Rosaniline Dyes; Suramin; Theophylline

1996
Purinergic modulation of rat urinary bladder detrusor smooth muscle.
    General pharmacology, 1997, Volume: 29, Issue:4

    Topics: Adenosine; Adenosine Triphosphate; Animals; Atropine; Caffeine; Electric Stimulation; In Vitro Techniques; Labetalol; Male; Muscle, Smooth; Purinergic Agonists; Purinergic Antagonists; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Quinidine; Rats; Rats, Wistar; Receptors, Purinergic; Urinary Bladder

1997
In vivo modulation of CYP enzymes by quinidine and rifampin.
    Clinical pharmacology and therapeutics, 2000, Volume: 68, Issue:4

    Topics: Acetylation; Administration, Oral; Adrenergic alpha-Antagonists; Adult; Anti-Arrhythmia Agents; Antibiotics, Antitubercular; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Caffeine; Central Nervous System Stimulants; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dapsone; Debrisoquin; Drug Administration Schedule; Enzyme Inhibitors; Humans; Male; Mephenytoin; Mixed Function Oxygenases; Quinidine; Reference Values; Rifampin; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Theophylline

2000
[Comparison of blocking and deblocking substances in diaphragm-phrenicus preparation in rat. II].
    Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie, 1954, Volume: 222, Issue:6

    Topics: Abdominal Muscles; Animals; Caffeine; Calcium; Calcium, Dietary; Diaphragm; Muscle Relaxants, Central; Neuromuscular Junction; Parasympathomimetics; Quinidine; Rats

1954
BIODYNAMICS OF THIOUREA-ALKALOID COMBINATIONS.
    The Journal of pharmacology and experimental therapeutics, 1963, Volume: 141

    Topics: Absorption; Alkaloids; Anti-Bacterial Agents; Blood Chemical Analysis; Caffeine; Intestines; Metabolism; Penicillins; Pharmacology; Quinidine; Quinine; Rats; Research; Salicylic Acid; Thiourea

1963
[ANALYSIS OF GALENIC PREPARATIONS. QUINA-KOLA SYRUP].
    Bollettino chimico farmaceutico, 1964, Volume: 103

    Topics: Caffeine; Chemistry, Pharmaceutical; Cinchona; Pharmacy; Quinidine; Quinine; Research

1964
Rate-limiting biotransformation of triamterene is mediated by CYP1A2.
    International journal of clinical pharmacology and therapeutics, 2005, Volume: 43, Issue:7

    Topics: Caffeine; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythromycin; Humans; Hydroxylation; Ketoconazole; Kinetics; Microsomes, Liver; Omeprazole; Quinidine; Substrate Specificity; Sulfuric Acid Esters; Theophylline; Triamterene

2005
Effect of caffeine on quinidine transport to the central nervous system in rats.
    Journal of basic and clinical physiology and pharmacology, 2007, Volume: 18, Issue:1

    Topics: Animals; Biological Transport, Active; Blood-Brain Barrier; Brain; Caffeine; Central Nervous System Stimulants; Drug Synergism; Female; Injections, Intra-Arterial; Male; Quinidine; Rats; Rats, Wistar

2007
Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
    Current drug safety, 2009, Volume: 4, Issue:2

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Triphosphate; Analgesics, Opioid; Animals; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Morphine Dependence; Muscle, Smooth; Naloxone; Narcotic Antagonists; Narcotics; Phenethylamines; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinidine; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Purinergic P2; Substance Withdrawal Syndrome; Theobromine; Theophylline

2009
The sugar meal of the African malaria mosquito Anopheles gambiae and how deterrent compounds interfere with it: a behavioural and neurophysiological study.
    The Journal of experimental biology, 2013, Apr-01, Volume: 216, Issue:Pt 7

    Topics: Action Potentials; Analysis of Variance; Animals; Anopheles; Berberine; Caffeine; Chemoreceptor Cells; Feeding Behavior; Female; Fructose; Glucose; Microscopy, Electron, Transmission; Nigeria; Quaternary Ammonium Compounds; Quinidine; Quinine; Sensilla; Sucrose

2013
Detection of Cutting Agents in Drug-Positive Seized Exhibits within the United States.
    Journal of forensic sciences, 2019, Volume: 64, Issue:3

    Topics: Acetaminophen; Caffeine; Chromatography, Liquid; Drug Contamination; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Kentucky; Levamisole; Procaine; Quinidine; Quinine; Vermont

2019